Compare CYD & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CYD | ACHC |
|---|---|---|
| Founded | 1951 | 2005 |
| Country | Singapore | United States |
| Employees | 8930 | N/A |
| Industry | Industrial Machinery/Components | Medical Specialities |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.3B |
| IPO Year | 1994 | N/A |
| Metric | CYD | ACHC |
|---|---|---|
| Price | $35.50 | $14.53 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 13 |
| Target Price | N/A | ★ $24.00 |
| AVG Volume (30 Days) | 112.3K | ★ 3.3M |
| Earning Date | 08-08-2025 | 11-05-2025 |
| Dividend Yield | ★ 1.48% | N/A |
| EPS Growth | ★ 40.10 | N/A |
| EPS | ★ 1.66 | 1.18 |
| Revenue | $3,159,401,156.00 | ★ $3,265,548,000.00 |
| Revenue This Year | $41.12 | $6.50 |
| Revenue Next Year | $6.93 | $4.38 |
| P/E Ratio | $21.61 | ★ $12.46 |
| Revenue Growth | ★ 17.99 | 4.58 |
| 52 Week Low | $9.32 | $12.63 |
| 52 Week High | $42.60 | $47.08 |
| Indicator | CYD | ACHC |
|---|---|---|
| Relative Strength Index (RSI) | 47.85 | 40.10 |
| Support Level | $35.32 | $14.05 |
| Resistance Level | $36.15 | $14.76 |
| Average True Range (ATR) | 0.97 | 0.53 |
| MACD | 0.09 | 0.24 |
| Stochastic Oscillator | 30.42 | 63.73 |
China Yuchai International Ltd is a Bermuda holding company that is a subsidiary of Singapore-based Hong Leong Asia. China Yuchai International operates through its majority-owned subsidiary Guangxi Yuchai Machinery Company, a China-based company that manufactures, assembles, and distributes diesel engines for various vehicles including trucks, buses, and cars, as well as construction and agricultural, marine, and power-generation equipment. It generates the majority of its sales from the Chinese market.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.